Visi-Pro™ PXB35-05-27-135Recalls & reported problems
Covidien LP · PXB35-05-27-135 STENT VISI PRO 035 V01 · Class 3 · Implant
All models of Visi-Pro (66)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00643169787605), received between Dec 17, 2019 and Jul 9, 2025 — classified as 2 injuries.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Device Dislodged or Dislocated1
- Fracture1
Patient problems
- Abdominal Pain1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 9, 2025Detachment of Device or Device Component; Device Dislodged or Dislocated; Detachment of Device or Device Component; Device Dislodged or Dislocated
IT WAS REPORTED THAT DURING A PROCEDURE INVOLVING THE STENT PXB35-05-27-135 VISI PRO 035 AND STENT PXB35-05-37-135 VISI PRO 035, THE FIRST STENT DETACHED FROM THE BALLOON AT THE TARGET LESION AND WAS SUBSEQUENTLY PULLED BACK AND DEPLOYED IN THE BRACHIAL ARTERY, WHICH WAS NOT THE INTENDED TARGET SITE. A SECOND STENT WAS THEN USED, BUT IT ALSO DETACHED FROM THE BALLOON IN THE AORTA JUST OUTSIDE OF THE SHEATH, WAS CAPTURED, PULLED BACK, AND DEPLOYED IN THE BRACHIAL ARTERY, AGAIN NOT AT THE INTENDED TARGET SITE. THERE WAS NO INJURY/INTERVENTION ASSOCIATED WITH THIS EVENT. THE PROCEDURE WAS THEN ABORTED. MODERATE RESISTANCE WAS ENCOUNTERED WHEN ADVANCING THE FIRST DEVICE, BUT NO EXCESSIVE FORCE WAS USED. BOTH STENTS REMAINED IMPLANTED IN THE BRACHIAL ARTERY. THE TARGET VESSEL WAS THE RENAL ARTERY/BRACHIAL ARTERY WITH A DIAMETER OF 5MM AND A COOK 6F SHEATH WAS USED. NO EMBOLIC PROTECTION, PRE-DILATION, OR POST-DILATION WAS PERFORMED. THE INSTRUCTIONS FOR USE WERE FOLLOWED WITHOUT ISSUE. NO PATIENT INJURY WAS REPORTED, AND THE PATIENT WAS ALIVE WITH NO INJURY. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 22459459 ↗InjuryDec 17, 2019Fracture; Fracture
VISIPRO STENT WAS IMPLANTED IN THE SUPERIOR MESENTERIC ARTERY. IT WAS REPORTED THAT STENT FRACTURE OCCURRED A FEW MONTHS AFTER DEPLOYMENT. PATIENT COMPLAINED OF ABDOMINAL PAIN AND WAS RE-IMAGED TO FIND THE ORIGINAL STENT IN TWO PIECES. NO FURTHER PATIENT INJURY WAS REPORTED FOR THIS EVENT.
Patient problems: Abdominal Pain
MAUDE report 9480456 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page